RACTHERA
LIVE

Serial Number

79433668

Owner

RACTHERA Co., Ltd.

Attorney

Charles T.J. Weigell

Filing Date

May 8, 2025

Add to watchlist:

No watchlists yet
View on USPTO

RACTHERA Trademark

Serial Number: 79433668

RACTHERA is a trademark filed by RACTHERA Co., Ltd. on May 8, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

RACTHERA Co., Ltd. (12 trademarks)

7-1, Nihonbashi 2-Chome,

Entity Type: 03

Trademark Details

Filing Date

May 8, 2025

Registration Date

Not Registered

Published for Opposition

September 22, 2026

Goods & Services

Medical information services in relation to pharmaceuticals; medical information services in relation to gene therapy; medical information services in relation to regenerative medicine; medical analysis services relating to the treatment of persons and provision of medical information in relation to pharmaceuticals and regenerative medical products; provision of medical information containing clinical data of patients; medical analysis services relating to the treatment of persons and provision of medical information; stem cell bank services; human tissue bank services; cultured cell bank services for medical transplantation; medical screening; medical testing services; provision of health information; health counselling; health care; consulting services in the field of health; dietary and nutritional guidance; rental of medical apparatus and instruments; rental of medical equipment

Stem cells for research purposes; stem cells for scientific purposes; stem cells, other than for medical or veterinary purposes; biological tissue cultures, other than for medical or veterinary purposes; cell culture media for scientific and research purposes; cell culture reagents for scientific and research use; media for bacteriological cultures, other than for medical or veterinary purposes; biochemical reagents for bacteriological cultures, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes; diagnostic reagents and preparations, except for medical or veterinary use; reagents for scientific purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; biochemical preparations for scientific purposes; chemicals for use in the manufacture of pharmaceuticals; industrial chemicals; chemicals for use in biological or biotechnological product development; biological preparations for use in biological or biotechnological product development, other than for medical or veterinary purposes

Testing, inspection, research or development of pharmaceuticals; providing information, advice and consultancy services relating to testing, inspection, research or development of pharmaceuticals; testing, inspection, research or development of regenerative medical products; providing information, advice and consultancy services relating to testing, inspection, research or development of regenerative medical products; medical and scientific research, namely, conducting clinical trials for others; testing, inspection or research of stem cells; providing information, advice and consultancy services relating to testing, inspection or research of stem cells; gene therapy research, and testing or inspection of gene therapy pharmaceuticals; providing information, advice and consultancy services relating to gene therapy research, and testing or inspection of gene therapy pharmaceuticals; testing, inspection or research of medicine in the field of gene therapy; providing information, advice and consultancy services relating to testing, inspection or research of medicine in the field of gene therapy; testing, inspection or research of regenerative medicine; providing information, advice and consultancy services relating to testing, inspection or research of regenerative medicine; testing, inspection or research of cells for medical use and medical technology in the field of cell therapy; providing information, advice and consultancy services relating to testing, inspection or research of cells for medical use and medical technology in the field of cell therapy; product testing and scientific research in the field of chemistry; product testing and scientific research in the field of biology; research and development of pharmaceuticals and regenerative medical products for others; research and development of new products for others; scientific research; scientific laboratory services; testing, inspection, research or development of medical apparatus and instruments; providing information, advice and consultancy services relating to testing, inspection, research or development of medical apparatus and instruments; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; providing information, advice and consultancy services relating to testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; software as a service (SaaS) services featuring software for use in data and database management; software as a service (SaaS) services featuring software for use in quality control, manufacturing process control, intraoperative adjustment in the operating room and management of transplantation procedures of cell therapy pharmaceuticals; platform as a service (PaaS) services featuring computer software platforms for use in data and database management; platform as a service (PaaS) services featuring computer software platforms for use in quality control, manufacturing process control, intraoperative adjustment in the operating room and management of transplantation procedures of cell therapy pharmaceuticals; server hosting; electronic data storage; providing temporary use of online non-downloadable software computer programs for use in data and database management; providing temporary use of online non-downloadable computer software programs for use in quality control, manufacturing process control, intraoperative adjustment in the operating room and management of transplantation procedures of cell therapy pharmaceuticals; computer system design; development of computer platforms; software engineering services for data processing; computer programming services; computer software design, computer programming, and maintenance of computer software; off-site data backup; recovery of computer data; computer security consultancy; telecommunication network security consultancy; information technology (IT) support services, namely troubleshooting of computer software problems

Biological tissue cultures for medical purposes or veterinary purposes; cells for medical purposes; living cells for medical purposes or veterinary purposes; stem cells for medical purposes or veterinary purposes; cell culture media for medical purposes or veterinary purposes; cell culture reagents for medical purposes or veterinary purposes; media for bacteriological cultures for medical purposes or veterinary purposes; reagents for bacteriological cultures for medical or veterinary purposes; chemical reagents for medical or veterinary purposes; cellular function activating agents for medical purposes; diagnostic reagents for medical or veterinary use; diagnostic preparations for medical or veterinary purposes; biochemical preparations for medical or veterinary purposes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemico-pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; enzymes for medical purposes

Electroencephalographs; pulse meters; body composition monitors; physical exercise apparatus for medical purposes; tomographs for medical purposes; diagnostic apparatus for medical purposes for use in medical laboratories for testing damaged genes, cells and tissues in the human or animal body in order to determine the suitability of regenerative medicine, cell therapy, and gene therapy; MRI apparatus for medical purposes; medical apparatus and instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of damaged tissues or other tissue-based diagnostic testing, cytology and cell-based testing, and genetics or gene-based testing; medical diagnostic instruments for the analysis of body fluids, somatic cells, stem cells, genes and tissues; genetic testing apparatus for medical purposes; apparatus for the regeneration of stem cells for medical purposes; surgical apparatus and instruments; robotic exoskeleton suits for medical purposes; body rehabilitation apparatus for medical purposes; medical apparatus and instruments for use in supporting, holding, or manipulating surgical instruments intraoperatively, or observing affected areas for cell therapy or gene therapy procedures and structural parts and accessories in the nature of arm connecting component therefor; medical apparatus and instruments for use in supporting, holding, or manipulating surgical instruments, namely, robotic arms and retractor arms; medical apparatus and instruments for use in observing affected areas for cell therapy or gene therapy, namely, surgical microscope arms and surgical assistance system comprising imaging module, infrared sensors, and image display devices

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 28, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 20, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 20, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 20, 2026 TROA
REFUSAL PROCESSED BY IB
Mar 19, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 27, 2026 RFCS
REFUSAL PROCESSED BY MPU
Feb 27, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 31, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jan 30, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 29, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 28, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 28, 2026 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 23, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 2, 2025 REPR